Latest News

Monday, July 25, 2016 | Conferences

Meeting Scheduled for International Forum for Scleral Lens Research (IFSLR)

The first International Forum for Scleral Lens Research (IFSLR) is scheduled for December 5, 2016 at the Texas Eye Research and Technology Center, University of Houston College of Optometry. The IFSLR…

Read the full story

Monday, July 25, 2016 | Management/Leadership, ReVision Optics

ReVision Optics Appoints Frank Shields Vice President of Sales Worldwide

ReVision Optics announced the appointment of Frank Shields to the newly created position of vice president of sales worldwide, effective immediately. Mr. Shields brings more than 25 years of experienc…

Read the full story

Monday, July 25, 2016 | Medical Studies

Cataract Surgery Has No Clear Link With AMD: Korean Survey

This is a cross-sectional study and cannot assess progression of AMD, but instead only analyze its association with cataract surgery. It was done in a predominantly Asian population who probably have …

Read the full story

Monday, July 25, 2016 | Medical Studies

CDC, AAP Update Recs for Infants and Congenital Zika Virus

The Centers for Disease Control and Prevention (CDC) and the American Academy of Pediatrics (AAP) have updated recommendations for the clinical evaluation and management of infants with congenital Zik…

Read the full story

Monday, July 25, 2016 | Clinical Trials, Ocular Therapeutix

FDA Does Not Approve Ocular Therapeutix's Dextenza for Postoperative Pain, Citing Manufacturing Deficiencies

Ocular Therapeutix announced that the FDA did not approved its new drug application (NDA) for Dextenza (dexamethasone insert) 0.4 mg, for intracanalicular use in the treatment of ocular pain occurring…

Read the full story

Friday, July 22, 2016 | Management/Leadership, Shire

Beth Marsh Joins Shire's Ophthalmics Team as Commercial Strategy Lead for Infectious Conjunctivitis Drug Candidate

Beth Marsh recently joined Shire's ophthalmics team as Commercial Strategy Lead for SHP640, the development program for a novel agent being investigated to treat infectious conjunctivitis (adenovi…

Read the full story

Friday, July 22, 2016 | Cataract Surgery, Medical Studies, Imprimis Pharmaceuticals

Peer-Reviewed Study of Dropless Cataract Surgery Shows 'Measurable Benefits' Compared to Drops

Imprimis Pharmaceuticals announced that positive results of a clinical study comparing the efficacy of its injected triamcinolone acetonide, moxifloxacin hydrochloride, and vancomycin (Tri-Moxi-Vanc) …

Read the full story

Friday, July 22, 2016 | Patents, Inotek Pharmaceuticals

Inotek Pharmaceuticals Expands Intellectual Property Portfolio with Combination Patent for IOP Lowering

Inotek Pharmaceuticals announced that the United States Patent and Trademark Office issued a composition of matter patent for the combination of the company’s lead product candidate, trabod…

Read the full story

Friday, July 22, 2016 | Health Care

CMS Release Proposed Medicare Fee Schedule to Impact Optometry Practices

A proposed rule for Medicare's 2017 Physician Fee Schedule contains several policies that will impact doctors of optometry participating in postoperative care, diabetes care and Medicare Advantage…

Read the full story

Friday, July 22, 2016 | Miscellaneous, Bausch+Lomb, Valeant

FDA Raises Manufacturing Concerns in Complete Response Letter for Valeant's Vesneo Eye Drop

The FDA issued a complete response letter to Valeant Pharmaceuticals in relation to its filing for Vesneo (latanoprostene bunod), an IOP-lowering single-agent eye drop for patients with open angle gla…

Read the full story

Friday, July 22, 2016 | Medical Studies

Endophthalmitis Risk Low After Intravitreal Injection

Only 30 cases of endophthalmitis occurred after 90,339 intravitreal injections, and prophylactic antibiotics did not decrease the rate of infections, a recent study suggests. Most physicians no longer…

Read the full story

Thursday, July 21, 2016 | Medical Studies, American Academy of Ophthalmology, Second Sight Medical Products

Five-Year Results of the Argus II Device Published

After 5 years, researchers say the Argus II retinal prosthesis system remains a safe and beneficial way to return functional vision to patients who are blind from retinitis pigmentosa, according to a …

Read the full story

Thursday, July 21, 2016 | Medical Studies

Detecting and Treating Glaucoma in a Myopic Patient Without High IOP

The prevalence of myopia is increasing both in the United States and worldwide. Between 1971 and 1972, the National Health and Nutrition Examination Survey (NHANES) estimated that 25% of the US popula…

Read the full story

Thursday, July 21, 2016 | Medical Studies

Is a Refractive Cataract Fellowship Needed?

CRST has devoted countless pages to optimizing the refractive outcome of cataract surgery. Contributors have shared their insights into managing astigmatism, honing nomograms, refining surgical techni…

Read the full story

Thursday, July 21, 2016 | Medical Studies

Florida, CDC Looking Into Possible First Homegrown Zika Case

Public health officials in Florida are investigating a laboratory-confirmed case of Zika infection in the Miami area that appears to be unrelated to travel, according to the Centers for Disease Contro…

Read the full story
Load More